This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Initial Jobless Claims Decline, BOE Keeps Policy Unchanged
by Zacks Equity Research
Stock futures point to a higher opening today as Weekly Jobless Claims data displayed a decline.
Cigna (CI) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Cigna (CI) delivered earnings and revenue surprises of 5.65% and 4.46%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Cigna's (CI) Earnings in Q2?
by Zacks Equity Research
Cigna's (CI) Q2 results are likely to reflect an increase in revenues but a decline in its bottom line.
Earnings Preview: Cigna (CI) Q2 Earnings Expected to Decline
by Zacks Equity Research
Cigna (CI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teladoc Health (TDOC) Q2 Loss Wider Than Expected, Worsen Y/Y
by Zacks Equity Research
Teladoc Health's (TDOC) Q2 earnings endure high expenses. Guidance shows tapering of growth.
Is Cigna (CI) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Zacks Analyst Blog Highlights: Johnson & Johnson, Oracle, SAP, Cigna and Walgreens Boots Alliance
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Johnson & Johnson, Oracle, SAP, Cigna and Walgreens Boots Alliance
Top Research Reports for Johnson & Johnson, Oracle & SAP
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Oracle (ORCL), and SAP SE (SAP).
Zacks Industry Outlook Highlights: MetLife, American International Group, Cigna, Prudential Financial and Horace Mann Educators Corp
by Zacks Equity Research
Zacks Industry Outlook Highlights: MetLife, American International Group, Cigna, Prudential Financial and Horace Mann Educators Corp
7 Multiline Insurers to Watch Out For as Economic Recovery Gains Traction
by Tanuka De
Better pricing, product redesigns, technological advancement along with optimistic growth outlook are expected to aid multiline insurers like MET, AIG, CI, HIG, PRU, AIZ and HMN as the impact of the pandemic recedes.
Is Cigna (CI) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why You Should Hold on to Cigna (CI) Stock for Now
by Zacks Equity Research
Cigna (CI) is currently riding on solid top-line growth, expanding global presence and prudent capital deployment.
UnitedHealth (UNH) Unit Opens Clinic to Ease Healthcare Access
by Zacks Equity Research
UnitedHealth Group's (UNH) subsidiary Optum launches Optum Mobile Clinic, which aims to facilitate easy access to quality healthcare services across 10 U.S. counties.
Should Value Investors Choose Cigna Corporation (CI) Stock?
by Zacks Equity Research
Let's see if Cigna Corporation (CI) stock is a good choice for value-oriented investors right now from multiple angles.
Humana (HUM) Boosts Presence in West Virginia With New Deal
by Zacks Equity Research
Humana (HUM) gets contract renewal from PEIA, which intends to offer better healthcare services to Medicare retirees of West Virginia.
Humana's (HUM) Unit To Enter Atlanta to Serve Aging Population
by Zacks Equity Research
Humana's (HUM) CenterWell unit lay plans to introduce six centers offering high-quality care to local senior patients across Atlanta.
Hologic (HOLX) Acessa Procedure Now Covered by Cigna Insurance
by Zacks Equity Research
Hologic's (HOLX) Acessa procedure new coverage will further validate Laparoscopic Radiofrequency Ablation as a standard of care for uterine fibroids.
Zacks Industry Outlook Highlights: American International Group, Cigna Corp, MetLife and Prudential Financial
by Zacks Equity Research
Zacks Industry Outlook Highlights: American International Group, Cigna Corp, MetLife and Prudential Financial
UnitedHealth (UNH) Unit to Offer Better Care in Central New York
by Zacks Equity Research
UnitedHealth Group's (UNH) subsidiary Optum collaborates with Bassett to offer enhanced and cost-effective healthcare services to Central New York patients.
Multiline Insurance Industry Gains 20% YTD: Stocks in Focus
by Tanuka De
Better pricing, product diversification and increased adoption of technology are expected to aid multiline insurers like CI, AIG, PRU, and MET.
Cigna (CI) Rides on Acquisitions, Strong Capital Deployment
by Zacks Equity Research
Cigna (CI) looks well poised for growth on the back of its acquisitions, membership strength and other growth strategies.
SOC Telemed (TLMD) Aids Virtual Service Expansion of SCP Health
by Sapna Bagaria
SOC Telemed (TLMD) offers its cloud-based Telemed IQ platform to expedite SCP Health's virtual care expansion.
Cigna (CI), Oscar to Address Needs of Arizona's Small Businesses
by Zacks Equity Research
Cigna (CI) joins forces with Oscar Health to extend its health insurance product to small business units across Arizona.
Will Teladoc (TDOC) Feel the Heat From SOC Telemed's Expansion?
by Zacks Equity Research
SOC Telemed's fund-raising program through investors for the second consecutive year to expand its operations might intensify competition for Teladoc Health (TDOC).
Zacks Industry Outlook Highlights: UnitedHealth Group, Anthem, Cigna Corp and Humana
by Zacks Equity Research
Zacks Industry Outlook Highlights: UnitedHealth Group, Anthem, Cigna Corp and Humana